[A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy].
A 35-year-old woman with taxane and anthracycline-resistant recurrent breast cancer with multiple lung metastasis and carcinomatous lymphangitis was treated with CMF as third-line chemotherapy. A complete response was achieved,and the toxicities were tolerable. We thought that CMF could be a useful regimen as third-line chemotherapy for metastatic breast cancer.
Yoshino
Hiroshi
H
Dept. of General and Gastroenterological Surgery, Ishikawa Prefectural Central Hospital.
Kinoshita
Seichi
S
Emori
Natsuko
N
Kadoya
Shinichi
S
Hiranuma
Chikashi
C
Ishiguro
Kaname
K
Koizumi
Hiroshi
H
Morita
Katsuya
K
Bando
Hiroyuki
H
Murakami
Nozomu
N
Yamada
Tetsuji
T
D000328:Adult; D018943:Anthracyclines / Q000494:pharmacology; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D001952:Bridged-Ring Compounds / Q000494:pharmacology; D017024:Chemotherapy, Adjuvant; D003520:Cyclophosphamide / Q000008:administration & dosage; D004334:Drug Administration Schedule; D019008:Drug Resistance, Neoplasm; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D008205:Lymphangitis / Q000209:etiology; D008727:Methotrexate / Q000008:administration & dosage; D011788:Quality of Life; D012074:Remission Induction; D013629:Tamoxifen / Q000008:administration & dosage; D043823:Taxoids / Q000494:pharmacology
D018943:Anthracyclines; D018931:Antineoplastic Agents, Hormonal; D001952:Bridged-Ring Compounds; D043823:Taxoids; D013629:Tamoxifen; C080625:taxane; D003520:Cyclophosphamide; D005472:Fluorouracil; D008727:Methotrexate